The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating gender as a predictive marker for response to bevacizuamb (Bev) in metastatic colorectal carcinoma (mCRC): Pooled analysis of 3369 patients (pts) in the ARCAD database.
 
Ofer Margalit
No Relationships to Disclose
 
William S. Harmsen
No Relationships to Disclose
 
Einat shacham-Shmueli
No Relationships to Disclose
 
Molly Petersen
No Relationships to Disclose
 
Ben Boursi
No Relationships to Disclose
 
Leonard B. Saltz
Consulting or Advisory Role - McNeil PPC (I)
Research Funding - Taiho Pharmaceutical
 
Richard Adams
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; SERVIER
Consulting or Advisory Role - Amgen; Merck Serono; SERVIER
Speakers' Bureau - Merck Serono
Travel, Accommodations, Expenses - Amgen; Merck Serono; SERVIER
 
Tim Maughan
Consulting or Advisory Role - vertex
 
Jean-Yves Douillard
No Relationships to Disclose
 
Eric Van Cutsem
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
Herbert Hurwitz
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
Consulting or Advisory Role - Acceleron Pharma; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Incyte; Lilly; Novartis; OncoMed; TRACON Pharma
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Macrogenics (Inst); NCI (Inst); Novartis (Inst); Regeneron (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Methods for treatment of Hand Foot Syndrome
 
Carsten Bokemeyer
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck KGaA; Roche; Sanofi; Servier/Pfizer
Consulting or Advisory Role - AOK Health Insurance; Bayer Schering Pharma; GSO; Hexal; Lilly/ImClone; Merck Serono; Merck Sharp & Dohme; Mundipharma; Sanofi
Research Funding - several companies in coooperation for clincal studies and for preclinical laboratory work (at my institution more than 100 ongoing reserach projects) (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pfizer; Sanofi
 
Niall C. Tebbutt
Honoraria - Amgen; Bristol-Myers Squibb; Eisai; Merck Sharp & Dohme; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Eisai; Merck Sharp & Dohme; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bayer; Roche
 
Fairooz F. Kabbinavar
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Aimery De Gramont
Honoraria - Chugai Pharma; Yakult Pharmaceutical
 
Qian Shi
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche